BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 21723447)

  • 1. Microvascular coronary dysfunction in women: pathophysiology, diagnosis, and management.
    Kothawade K; Bairey Merz CN
    Curr Probl Cardiol; 2011 Aug; 36(8):291-318. PubMed ID: 21723447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety of coronary reactivity testing in women with no obstructive coronary artery disease: results from the NHLBI-sponsored WISE (Women's Ischemia Syndrome Evaluation) study.
    Wei J; Mehta PK; Johnson BD; Samuels B; Kar S; Anderson RD; Azarbal B; Petersen J; Sharaf B; Handberg E; Shufelt C; Kothawade K; Sopko G; Lerman A; Shaw L; Kelsey SF; Pepine CJ; Merz CN
    JACC Cardiovasc Interv; 2012 Jun; 5(6):646-53. PubMed ID: 22721660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coronary endothelial dysfunction in non-obstructive coronary artery disease: Risk, pathogenesis, diagnosis and therapy.
    Shaw J; Anderson T
    Vasc Med; 2016 Apr; 21(2):146-55. PubMed ID: 26675331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of Coronary Microvascular Dysfunction Among Patients With Chest Pain and Nonobstructive Coronary Artery Disease.
    Sara JD; Widmer RJ; Matsuzawa Y; Lennon RJ; Lerman LO; Lerman A
    JACC Cardiovasc Interv; 2015 Sep; 8(11):1445-1453. PubMed ID: 26404197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coronary Microvascular Function and Cardiovascular Risk Factors in Women With Angina Pectoris and No Obstructive Coronary Artery Disease: The iPOWER Study.
    Mygind ND; Michelsen MM; Pena A; Frestad D; Dose N; Aziz A; Faber R; Høst N; Gustafsson I; Hansen PR; Hansen HS; Bairey Merz CN; Kastrup J; Prescott E
    J Am Heart Assoc; 2016 Mar; 5(3):e003064. PubMed ID: 27068634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reappraisal of Ischemic Heart Disease.
    Kaski JC; Crea F; Gersh BJ; Camici PG
    Circulation; 2018 Oct; 138(14):1463-1480. PubMed ID: 30354347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microvascular Coronary Dysfunction-an Overview.
    Naderi S
    Curr Atheroscler Rep; 2018 Jan; 20(2):7. PubMed ID: 29383530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac magnetic resonance myocardial perfusion reserve index is reduced in women with coronary microvascular dysfunction. A National Heart, Lung, and Blood Institute-sponsored study from the Women's Ischemia Syndrome Evaluation.
    Thomson LE; Wei J; Agarwal M; Haft-Baradaran A; Shufelt C; Mehta PK; Gill EB; Johnson BD; Kenkre T; Handberg EM; Li D; Sharif B; Berman DS; Petersen JW; Pepine CJ; Bairey Merz CN
    Circ Cardiovasc Imaging; 2015 Apr; 8(4):. PubMed ID: 25801710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimal Use of Vasodilators for Diagnosis of Microvascular Angina in the Cardiac Catheterization Laboratory.
    Rahman H; Demir OM; Ryan M; McConkey H; Scannell C; Ellis H; Webb A; Chiribiri A; Perera D
    Circ Cardiovasc Interv; 2020 Jun; 13(6):e009019. PubMed ID: 32519879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic microvascular dysfunction in microvascular and vasospastic angina.
    Ford TJ; Rocchiccioli P; Good R; McEntegart M; Eteiba H; Watkins S; Shaukat A; Lindsay M; Robertson K; Hood S; Yii E; Sidik N; Harvey A; Montezano AC; Beattie E; Haddow L; Oldroyd KG; Touyz RM; Berry C
    Eur Heart J; 2018 Dec; 39(46):4086-4097. PubMed ID: 30165438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac syndrome X and microvascular coronary dysfunction.
    Jones E; Eteiba W; Merz NB
    Trends Cardiovasc Med; 2012 Aug; 22(6):161-8. PubMed ID: 23026403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of angina and microvascular coronary dysfunction.
    Samim A; Nugent L; Mehta PK; Shufelt C; Bairey Merz CN
    Curr Treat Options Cardiovasc Med; 2010 Aug; 12(4):355-64. PubMed ID: 20842559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of phosphodiesterase type 5 inhibition on microvascular coronary dysfunction in women: a Women's Ischemia Syndrome Evaluation (WISE) ancillary study.
    Denardo SJ; Wen X; Handberg EM; Bairey Merz CN; Sopko GS; Cooper-Dehoff RM; Pepine CJ
    Clin Cardiol; 2011 Aug; 34(8):483-7. PubMed ID: 21780138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Typical angina is associated with greater coronary endothelial dysfunction but not abnormal vasodilatory reserve.
    AlBadri A; Leong D; Bairey Merz CN; Wei J; Handberg EM; Shufelt CL; Mehta PK; Nelson MD; Thomson LE; Berman DS; Shaw LJ; Cook-Wiens G; Pepine CJ
    Clin Cardiol; 2017 Oct; 40(10):886-891. PubMed ID: 28605043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coronary microvascular function and myocardial fibrosis in women with angina pectoris and no obstructive coronary artery disease: the iPOWER study.
    Mygind ND; Michelsen MM; Pena A; Qayyum AA; Frestad D; Christensen TE; Ghotbi AA; Dose N; Faber R; Vejlstrup N; Hasbak P; Kjaer A; Prescott E; Kastrup J;
    J Cardiovasc Magn Reson; 2016 Nov; 18(1):76. PubMed ID: 27809867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peripheral Endothelial Function and Coronary Flow Velocity Reserve Are Not Associated in Women with Angina and No Obstructive Coronary Artery Disease: The iPOWER Study.
    Flintholm Raft K; Frestad D; Michelsen MM; Suhrs HE; Rask AB; Nilsson M; Hermann TS; Prescott E
    J Vasc Res; 2017; 54(5):309-319. PubMed ID: 28942444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sex-specific factors in microvascular angina.
    Sedlak T; Izadnegahdar M; Humphries KH; Bairey Merz CN
    Can J Cardiol; 2014 Jul; 30(7):747-755. PubMed ID: 24582724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coronary flow velocity response to adenosine characterizes coronary microvascular function in women with chest pain and no obstructive coronary disease. Results from the pilot phase of the Women's Ischemia Syndrome Evaluation (WISE) study.
    Reis SE; Holubkov R; Lee JS; Sharaf B; Reichek N; Rogers WJ; Walsh EG; Fuisz AR; Kerensky R; Detre KM; Sopko G; Pepine CJ
    J Am Coll Cardiol; 1999 May; 33(6):1469-75. PubMed ID: 10334410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ischemia and No Obstructive Coronary Artery Disease: Prevalence and Correlates of Coronary Vasomotion Disorders.
    Ford TJ; Yii E; Sidik N; Good R; Rocchiccioli P; McEntegart M; Watkins S; Eteiba H; Shaukat A; Lindsay M; Robertson K; Hood S; McGeoch R; McDade R; McCartney P; Corcoran D; Collison D; Rush C; Stanley B; McConnachie A; Sattar N; Touyz RM; Oldroyd KG; Berry C
    Circ Cardiovasc Interv; 2019 Dec; 12(12):e008126. PubMed ID: 31833416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coronary slow flow or syndrome Y: dysfunction at rest, preserved reactivity of the peripheral endothelium.
    Muxel S; Fineschi M; Hauser ER; Gori T
    Int J Cardiol; 2011 Feb; 147(1):151-3. PubMed ID: 20488564
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.